Cullinan Therapeutics CGEM
NASDAQ CGEM
$11.35 +0.12 (+1.07%)
At close: Nov 11, 2026 · 4:00 PM EST

Cullinan Therapeutics (CGEM) EV to EBIT (2022 - 2023)

Updated

Cullinan Therapeutics' (CGEM) EV to EBIT was 0.10 for Q1 2023, down 6.2% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) EV to EBIT (2022 - 2023) Analysis & Trends

Over the twelve months ended Mar 31, 2023, Cullinan Therapeutics' EV to EBIT came in at -14.34; for FY2022, it was 0.11.

  • Five-year quarterly EV to EBIT spans a low of -0.19 in Q2 2022 and a high of 0.11 in Q4 2022.
  • Per Business Quant data, the three quarters before Q1 2023 came in at 0.11 (Q4 2022), 0.07 (Q3 2022) and -0.19 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cullinan Therapeutics 722.60 Mn -1.13 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 0.10
Dec 31, 2022 0.11
Sep 30, 2022 0.07
Jun 30, 2022 -0.19
API Access

Cullinan Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CGEM&period=max&api_key=YOUR_API_KEY